陳均豪

單位: 放射腫瘤科

現職:

  • 馬偕醫院放射腫瘤科資深主治醫師
  • 馬偕醫護管理專科學校專任助理教授

主要學歷:

  • 中國醫藥大學醫學系 (MD)
  • 陽明大學生物醫學影像暨放射科學研究所博士 (PhD)

主要經歷:

  • 放射腫瘤科專科醫師
  • 台灣安寧緩和醫學專科
  • Visiting clinician at Mayo Clinic College of Medicine and Science, Division of Radiation Oncology, Arizona USA (January 2019)

主治項目或專長:

  • 各種癌症之放射治療、中西醫癌症整合醫療、安寧療護

論文研究:

  1. YI-CHUN CHIEN, YING-HSIANG CHOU, WEI-HSUN WANG, JOHN CHUN-HAO CHEN, WEN-SHIN CHANG, CHIA-WEN TSAI, DA-TIAN BAU and JENG-JONG HWANG. Therapeutic Efficacy Evaluation of Pegylated Liposome Encapsulated With Vinorelbine plus 111In Repeated Treatments in Human Colorectal Carcinoma With Multimodalities of Molecular Imaging. Journal name: Cancer Genomics and Proteomics (CGP). 2019 (Accepted)
  2. Chen JC et al. Enhanced cytotoxicity of human hepatocellular carcinoma cells following pretreatment with sorafenib combined with trichostatin A. Oncol Lett. 2019 Jan;17(1):638-645.
  3. Chen JC et al. Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model. Oncotarget. 2016 Dec 20;7(51):85450-85463.
  4. Chien YC, Chen JC, Lin WC, Ding HJ, Wang HE, Kao CH, Hwang JJ. Using [¹⁸F]FBAU for imaging brain tumor progression in an F98/tk-luc glioma-bearing rat model. Oncol Rep. 2014 Aug;32(2):691-9.
  5. Hsu FT, Chang B, Chen JC, Chiang IT, Liu YC, Kwang WK, Hwang JJ,5.Synergistic Effect of Sorafenib and Radiation on Human Oral Carcinoma in vivo. Sci Rep. 2015 Oct 21;5:15391.